CEPTAZ INJECTION - PWS IV 2GM/VIAL
CEPTAZ INJECTION - PWS IV 2GM/VIAL
Discontinued
DIN Number
02215020
Drug Class
Human
Market Date
Dec 28, 2001
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02215020
AIG Number0116900002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD02 CEFTAZIDIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.06.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
CEFTAZIDIMEActive
Strength: 2 G / VIAL
Monograph: CEFTAZIDIME